🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Histiocytosis

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946Phase 16 sites📍 Duarte📍 St Louis📍 Buffalo LTZ Therapeutics, Inc. · Tests: LTZ-301, LTZ-301, LTZ-301 Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study NCT04665674n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Standard of care SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites📍 Denver📍 Atlanta📍 Fairway Verismo Therapeutics · Tests: SynKIR-310 Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Retinal Hyperspectral Imaging in Neurodegenerative Diseases NCT07545473NA1 site📍 Melbourne Center for Eye Research Australia · Tests: Hyperspectral camera Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions NCT07371182NA11 sites📍 Hefei📍 Nanning📍 Guiyang West China Second University Hospital · Tests: Luvometinib A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC) NCT07082725Phase 334 sites📍 Oakland📍 Minneapolis📍 Rochester Azafaros B.V. · Tests: Nizubaglustat, Placebo Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) NCT06299553n/a1 site📍 Milan Incyte Biosciences Italy S.r.l Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH NCT07187193Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Cytarabine (Ara-C), Thalidomide (100mg) Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) NCT07680933Phase 21 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: Orelabrutinib combined with standard immunochemotherapy with or without auto-HSCT Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children NCT07022834Phase 21 site📍 Chengdu West China Second University Hospital · Tests: Dabrafenib or Trametinib and Clofarabine AZA Combined With RCHOP in P53-mutated DLBCL. NCT06158399Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Azacitidine in combination with R-CHOP Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL NCT07778212NA2 sites📍 Xiamen📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Orelabrutinib Combined with Pola-R-CHP Regimen Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta NCT05950802Phase 11 site📍 Toronto University Health Network, Toronto · Tests: Cyclophosphamide, TLI Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses NCT03329274n/a1 site📍 New York Memorial Sloan Kettering Cancer Center GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma NCT05992532n/a23 sites📍 Vitoria-Gasteiz📍 Almería📍 Palma de Mallorca Fundación Española de Hematología y Hemoterapía Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict) NCT06526065n/a1 site📍 Göttingen University Medical Center Goettingen · Tests: no intervention A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C NCT05163288Phase 314 sites📍 Rochester📍 Parkville📍 Prague IntraBio Inc · Tests: N-Acetyl-L-Leucine, Placebo National Multicentre Study of the Natural History of Acid Sphingo-myelinase Deficiency in Adults and Children NCT06985212n/a1 site📍 Paris Wladimir MAUHIN, Dr Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Lenalidomide combined with G-CHOP (LO CHOP) Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes NCT06891157Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Chidamide plus R-CHOP A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma NCT06736613Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cerebral Spinal Fluid ctDNA Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site📍 Hangzhou Zhejiang Provincial People's Hospital · Tests: Mirabegron Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence NCT06078969Phase 21 site📍 Shanghai Shanghai Changzheng Hospital · Tests: Prednisone Mirdametinib in Histiocytic Disorders NCT06153173Phase 21 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Mirdametinib UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells NCT02254863Phase 11 site📍 Durham Joanne Kurtzberg, MD · Tests: DUOC-01 Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling NCT05857969Phase 11 site📍 Miami Florida International University · Tests: Functional Precision Medicine Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL NCT06287398Phase 21 site📍 Melbourne Australasian Leukaemia and Lymphoma Group · Tests: Epcoritamab Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy